European Journal of Heart Failure Supplements - recent issues

Editorial Board

2008-06-01

Levosimendan from Evidence to Experience

Mebazaa, A., Follath, F. — 2008-06-01

Levosimendan in the treatment of AHF: lessons from surveys and clinical trials

2008-06-01

Acute heart failure (AHF) is a primary cause of hospital admission throughout the world. Several acute heart failure registries have been conducted in the United States (U.S.) and Europe assessing the clinical presentation of AHF in the real world. Of the five large registries two were conducted in the U.S. are: the Acute Decompensated Heart Failure National Registry (ADHERE) [1], and Organized Program to Initiate Life Saving Treatment in Patients Hospitalized for Heart Failure (OPTIMIZE-HF) [2]. The other three are European registries: the EuroHeart Failure Survey (EHFS I and II) [3–5], the Italian Survey [6] and in France the Epidémiologie Francaise de l'lnsuffisance Cardiaque Aiguë (EFICA; French Epidemiology of Acute Heart Failure) [7]. These registries have described the clinical profile, the underlying pathophysiology, the relevant therapeutic interventions used in routine clinical practice, and short- and/or long term outcomes of AHF patients. However, the percentage of patients who received levosimendan in these surveys was very small in order to have valid data about the impact of this therapeutic approach on patients' clinical course and prognosis. In contrast, at least four randomized clinical trials (LIDO, RUSSLAN, REVIVE-II, SURVIVE) have assessed the safety and efficacy of levosimendan, providing clarification on important aspects of whether and through what means levosimendan improves short- and long term outcome of patients suffering from AHF. Levosimendan has also rapidly and significantly reduced Brain natriuretic peptide (BNP) levels in several studies, indicating a hemodynamic response. Therefore, serial measurements of B-type natriuretic peptides (BNP, NT-proBNP) may be a valuable tool in every day clinical practice in order to identify responders to levosimendan treatment and to optimize the overall treatment in AHF, predicting also future adverse clinical outcomes. However, this hypothesis should be further tested in randomized trials in a similar way to that examined in patients with chronic heart failure.

Levosimendan: a decade of experience in Europe built on years of evidence

2008-06-01

Recent European Society of Cardiology's (ESC) guidelines on the diagnosis and treatment of acute heart failure (AHF), suggest that an essential target in the management of these patients is to improve symptoms within hours, which should persist until hospital release, also protecting renal function and avoiding ongoing myocardial injury. The vast experience built on the basis of evidence, accumulated regarding the use of levosimendan over the last 10 years, brings with it the possibility of utilizing this drug in multitude of new clinical scenarios. Newly discovered biologic effects of the drug on the failing heart, based on its anti-inflammatory, anti-apoptotic and anti-oxidative properties may explain the clinical efficacy of levosimendan in special sub-populations of AHF patients. This paper summarizes the current knowledge regarding the use of levosimendan in the early phase of the treatment of AHF, in acute coronary syndromes, its daily use in the critical care environment, perioperatively, and in patients with renal failure.

33 The soluble guanylate cyclase activator BAY 58-2667 has a favourable safety profile and improves cardiopulmonary haemodynamics in acute decompensated heart failure

2008-06-01

34 Association of physician-determined worsening heart failure with signs and symptoms, hospitalization duration, and 60-day outcomes in patients hospitalised for acute heart failure

2008-06-01

35 Regional differences in baseline characteristics and outcomes in patients admitted with acute heart failure - results from the EVEREST program

2008-06-01

36 Diabetes is associated with increased risk of CV events in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial

2008-06-01

37 Combined testosterone and insulin-like growth factor deficiency impairs quadriceps strength in men with chronic heart failure

2008-06-01

38 Increased peripheral and central chemosensitivity in heart failure: a hidden pathogenetic trigger with an independent prognostic value

2008-06-01

39 The non-cardiological complications during heart failure hospitalizations: prevalence and impact on length of stay

2008-06-01

40 Exertional periodic breathing is frequent in heart failure patients: clinical and neuro-hormonal correlates

2008-06-01

41 Prognostic value of B-type natriuretic peptide levels in patients with constrictive pericarditis undergoing pericardiectomy

2008-06-01

42 Does troponin I (TnI) provide additional prognostic information to B-type natriuretic peptide (BNP) in patients hospitalised with decompensated Heart Failure (HF)?

2008-06-01

43 Precipitants of heart failure hospitalization and duration of symptom exacerbation: An opportunity for prevention

Stewart, T., Tofler, G. — 2008-06-01

44 Morbidity burden following class IV heart failure discharge: determining the need for ongoing care in a disease management programme

Constant, O., O'Loughlin, C., Murphy, N.F., McDonald, K. — 2008-06-01

45 Identification of high-risk patients in multidisciplinary heart failure clinics. An analysis from the Danish Heart Failure Clinics Network

Gustafsson, F., Schou, M., Videbaek, L., Ryde, H., Handberg, J., Hildebrandt, P. — 2008-06-01

46 Differences in clinical outcome of first time admitted heart failure patients compared to patients treated in a specialised heart failure unit

2008-06-01

47 Cost-effectiveness of remote monitoring of intra-thoracic impedance as part of Heart Failure disease management

Mullens, W., Abrahams, Z., Verga, T., Kelly, L., Wilkoff, B.L., Tang, W.H.W. — 2008-06-01

48 Non invasive hemodynamic monitoring and bedside BNP assessment as a guide to outpatients' management in a Heart Failure Clinic

2008-06-01

49 Implementing a novel integrated heart failure disease management program in Israel

2008-06-01

50 Care coordination and rehospitalization: Connecting the hospital with the medical home

Hsu, J., Huang, J. — 2008-06-01

51 Undertreatment of diabetic heart failure patients is prevented by referral to specialized heart failure clinics. An analysis from the Danish Heart Failure Clinics Network

2008-06-01

52 Telemedicine reduces hospitalisation rates in patients with chronic heart failure - results of the randomized HiTel trial

2008-06-01

53 Retrospective Heart Failure Clinic Study

Jain, R., Evenson, A., Jain, R., Nanavaty, U., Punnam, J., Plantholt, S. — 2008-06-01

54 Haemoglobin level influences clinical and psychological parameters in patients with Chronic Heart Failure

Latina, L., Cemin, R., Egger, F., Donolato, P., Tarantini, L., Pitscheider, W. — 2008-06-01

55 Post-discharge home surveillance of BNP levels allows early identification of decompensation and reduces readmission

2008-06-01

56 Follow-up of patients implanted with cardiac electric devices

2008-06-01

57 Depressed mood in Chronic Heart Failure patients predicts an increase in mortality and hospital admissions

2008-06-01

58 Depressive symptoms independently predict early rehospitalization for heart failure patients with preserved systolic function

Song, E.K., Moser, D.K., Lennie, T.A. — 2008-06-01

59 Barriers and supports for community-based palliative care for patients with heart failure

2008-06-01

60 New monitoring method of body fluid status by digital weight scale incorporating bioelectrical impedance analyzer in definite heart failure patients

Kataoka, H. — 2008-06-01

61 Pregnancy outcome in women with a systemic right ventricle - a single centre experience-University College London Hospitals NHS Trust

2008-06-01

62 Reduced clot permeability and susceptibility to lysis as a novel prothrombotic mechanism in patients with chronic heart failure

Nessler, J., Undas, A., Palka, I., Nessler, B., Tracz, W., Piwowarska, W. — 2008-06-01

63 Bone loss and fractures in congestive heart failure: effect of calcium and vitamin D supplementation

Abou-Raya, A., Abou-Raya, S., Helmii, M. — 2008-06-01

64 Hyponatremia in chronic heart failure patients with normal and impaired kidney function-influence on mortality and morbidity during one-year follow-up

Starczewska, M.H., Roik, M., Scislo, P., Kochanowski, J., Opolski, G. — 2008-06-01

65 Renal artery stenosis: independent predictor of increased mortality in patients with heart failure. A Magnetic Resonance Imaging study

2008-06-01

66 Evaluation of hand grip strength as a marker of clinical deterioration in heart failure patients

2008-06-01

67 Nutritional status as evalueted by pre-albumin is not a prognostic determinant in heart failure decompensation

2008-06-01

68 Predicting hospitalisation due to worsening heart failure using daily weight measurement: An analysis of the Trans-European Network-Home-Care Management System (TEM-HMS) Study

Zhang, J., Goode, K., Cuddihy, P., Cleland, J.G. — 2008-06-01

69 Evaluation of cardiac toxicity associated with preparative regimen and hematopoietic stem cell transplantation with multiple biochemical markers

Horacek, J.M., Pudil, R., Tichy, M., Jebavy, L. — 2008-06-01

70 An Asian comparison of cardiologist versus non-cardiologist care of heart failure

Ling, L.F., Shen, L., Chai, P. — 2008-06-01

71 Association between body composition and cardiac troponin T in heart failure patients

2008-06-01

72 Prevalence and prognostic significance of atherosclerotic disease of the aorta and its side branches in patients with chronic heart failure

2008-06-01

73 Role of mechanical stretch in modulating human cardiac fibroblast activity and extracellular matrix turnover

Watson, C.J., Phelan, D., Collier, P., Ledwidge, M., McDonald, K., Baugh, J. — 2008-06-01

74 Prevalence of sleep disordered breathing in diastolic heart failure

2008-06-01

75 The Canadian Cardiovascular Society (CCS) heart failure consensus conference program: shaping the future of heart failure management in Canada

Arnold, M., Howlett, J., Liu, P., Ross, H., Mckelvie, R., Pullen, C., Parker, J. — 2008-06-01

76 Sex differences in survival among patients with heart failure and preserved left ventricular ejection fraction. One year follow-up study

Roik, M., Starczewska, M.H., Kochanowski, J., Huczek, Z., Opolski, G. — 2008-06-01

77 Use an intermittent ultrafiltation in decompensated, diuretic resistant heart failure

2008-06-01

78 Submassive pulmonary embolism in patients with congestive heart failure

2008-06-01

79 Are there socio-economics barriers in heart failure management?

Calin, C.L., Sinescu, C.J. — 2008-06-01

80 Poor outcome of diabetic patients with coronary artery disease and coexisting heart failure

2008-06-01

81 Long-term outcome of patients with hypertension-related chronic systolic heart failure

2008-06-01

82 Implication of chronic obstructive pulmonary disease in elderly patients with stable chronic heart failure - It is ignored combination

2008-06-01

83 Alcohol consumption and risk of heart failure in the GISSI-PREVENZIONE Study

2008-06-01

84 Usefulness of plasma B-type Natriuretic peptide measurement for prediction of onset of Heart Failure and cardiovascular events in chronic kidney disease: a community-based longitudinal study

2008-06-01

85 Clinical characteristics and pattern of treatment of patients with renal dysfunction and chronic heart failure. Data from the GISSI Heart Failure Study

2008-06-01

86 Characteristics of heart failure in women: Chilean National Registry of Heart Failure

2008-06-01

87 Hot summers and heart failure: seasonal variations in morbidity and mortality in Australian heart failure patients (1994-2005)

2008-06-01

88 Anaemia in heart failure: Influence on clinical outcomes in a community population

Stewart, T., Tofler, G. — 2008-06-01

89 Prevalence of impaired relaxation pattern with normal ejection fraction - a population based study

2008-06-01

90 The Canadian Cardiovascular Society Heart Failure Guidelines implementation: initial results from the National Workshop Initiative

2008-06-01

91 State of knowledge regarding heart failure in the population

2008-06-01

92 Factors determining diagnosis of heart failure in accordance with ESC guidelines, Polish national, multicenter POLKARD program

2008-06-01

93 BNP argues against considering impaired relaxation pattern in the definition of stages of heart failure - a population based study

Goncalves, A., Dias, P., Pimenta, J., Frioes, F., Bettencourt, P., Azevedo, A. — 2008-06-01

94 Cardiovascular involvement in thalassemia major patients: WEBTHAL data analysis (a web based multicentric database)

2008-06-01

95 Gender differences in left ventricular hypertrophy, concentricity and renal function: data from the CArdio-REnal-MEtabolism registry

2008-06-01

96 Prevalence and prognosis of anaemiain post MI patients

Torabi, A., Cleland, J.G.F., Goode, K., Rigby, A.S. — 2008-06-01

97 Prevalence and prognosis of heart failure in different age group in post MI patients

Torabi, A., Cleland, J.G.F. — 2008-06-01

98 Risk assessment in Primary Care: can B-type Natriuretic Peptide tell us more?

2008-06-01

99 Long-term survival of patients with congestive heart failure and preserved left ventricular ejection fraction: 9 years of follow-up

2008-06-01

100 Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP study

2008-06-01

101 Is the reverse epidemiology in the era of statin therapy still actual among patients with heart failure and reduced or preserved left ventricular function?

Roik, M., Starczewska, M.H., Kochanowski, J., Huczek, Z., Opolski, G. — 2008-06-01

102 Effects of Darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure

2008-06-01

103 Symptoms of anxiety and depression in clinically stable CHF outpatients

Uszko-Lencer, N.H., Boyne, J., Spruit, M.A. — 2008-06-01

104 Chronic emotional stress increases infarct size in rats: The role oxidative damage in response to sympathetic hyperactivity

Mercanoglu, G., Safran, N., Eroglu, L. — 2008-06-01

105 First evaluation of a novel questionnaire for physical wellbeing in patients with heart failure

2008-06-01

106 Feasibility and burden of multidimensional assessement of heart failure elderly in clinical practice: data from the IMAGE-HF Study

2008-06-01

107 Development of phenotype and expression of contractile proteins & molecular markers of heart failure over time in beta1-receptor antibody-induced immune-cardiomyopathy

2008-06-01

108 Cardioprotective cyclic peptides and beta-blockers in the therapy of beta1-receptor antibody-induced cardiomyopathy: effects on phenotype and cardiac expression of ANP/BNP/Cytokines

2008-06-01

109 Association between toll-like receptor 8 expression and adverse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathy

Satoh, M., Ishikawa, Y., Minami, Y., Takahashi, Y., Nakamura, M. — 2008-06-01

110 The role of dyslipidemia in idiopathic dilated cardiomyopathy

2008-06-01

111 Evolution of systolic and diastolic dysfunction in hypertrophic cardiomyopathy: clinical and prognostic significance

2008-06-01

112 Thrombospondin-2 guards against aging-related cardiomyopathy by increasing beta 1-integrin mediated signaling

2008-06-01

113 Decreased expression of dystrophin: possibly an adverse effect of TNF-alpha in patient with dilated cardiomyopathy

2008-06-01

114 Alterations in sarcomeric protein expression, phosphorylation and contractile function in hypertrophic cardiomyopathy patients carrying a founder mutation in myosin binding protein C

2008-06-01

115 Predicting exercise capacity in patients with dilated cardiomyopathy by parameters of right ventricular function

Vormbrock, J., Plehn, G., Zuehlke, C., Machnick, S.A., Trappe, H.-J. — 2008-06-01

116 Gene expression signature of adrenaline biosynthesis and inflammatory pathways in women with left ventricular apical ballooning syndrome

2008-06-01

117 Echocardiographic characteristics of functional mitral regurgitation in ischaemic versus idiopathic dilated cardiomyopathy

2008-06-01

118 Increased cardiac CXCR4+/cKit+ cell density in patients with angina and cardiac Parvovirus B19 persistence

2008-06-01

119 End-stage congestive heart failure secondary to idiopathic dilated cardiomyopathy is accompanied by severe reduction of myocardial capillary density

2008-06-01

120 Prevalence of Sleep Disordered Breathing after discharge from acute heart failure episode

Huda, N., Hoque, M.Z., Ra, H., Sardi, G., Karia, D. — 2008-06-01

121 Left ventricular remodeling following anterior and inferior infarction: differences in LV geometry

Di Donato, M., Castelvecchio, S., Frigiola, A., Menicanti, L. — 2008-06-01

122 Assessment of regional left ventricular function in isolated left ventricular noncompaction

Varga-Szemes, A., Toth, L., Faludi, R., Papp, L., Simor, T. — 2008-06-01

123 Evaluation of ADMA as a risk marker and prognostic factor in patients with heart failure

2008-06-01

124 The transient left ventricular Apical Ballooning Syndrome or Tako-Tsubo Cardiomyopathy: A single center experience

Rotzak, R., Tobar, R., Krivistky, M., Turkisher, V., Tamari, I., Rozenman, Y. — 2008-06-01

125 Idiopathic dilated cardiomyopathy in children: natural history and predictors of prognosis

Saad, I. — 2008-06-01

126 Testosterone efficiency at the patients with dilated cardiomyopathy

Abdullaev, T. — 2008-06-01

127 Favourable mid-term clinical and echocardiographical follow-up of patients with transient left ventricular apical ballooning

2008-06-01

128 Cardiomyopathy and kidney disease in a patient with maternally inherited diabetes and deafness

2008-06-01

129 Echocardiografic evaluation, physical capacity and NTproBNP concentration in dilated cardiomyopathy patients wit low and elevated trasnspulmonary gradient

2008-06-01

130 Sleep Disordered Breathing in acute decompensated Heart Failure: prevalence, incidence and relation with hemodynamics

Karia, D., Huda, N., Ra, H., Ishac, R., Hoque, M.Z., Morris, D.L. — 2008-06-01

131 Low molecular fish extract decreases mortality in the mouse model of doxorubicin induced acute heart failure

2008-06-01

132 Prognostic role of persistence of significant functional mitral regurgitation in idiopathic dilated cardiomyopathy

2008-06-01

133 Atrial fibrillation in hypertrophic cardiomyopathy: influence in the outcome

Brito, D., Sargento, L., Madeira, H. — 2008-06-01

134 Regional myocardial sympathetic denervation may contribute for the genesis of sustained ventricular tachycardia in patients with chronic Chagas cardiomyopathy

2008-06-01

135 Long-term exercise capacity of patients with hypertrophic cardiomyopathy treated with percutaneous alcohol septal myocardial ablation

2008-06-01

136 Low-dose rather than high-dose erythropoietin may be effective in a rat model of dilated cardiomyopathy that is not anaemic

Kono, T., Nakagawa, D., Soyama, A., Tanaka, T., Kohda, Y., Kitaura, Y. — 2008-06-01

137 Role of heart rate variability for early detection of anthracycline-induced cardiotoxicity and prediction of reduction in left ventricular ejection fraction

Kalinkina, N., Vatutin, N. — 2008-06-01

138 Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas cardiomyopathy

2008-06-01

139 Secondary cardiomyopathy in patients with Beta-thalassemia major: a model of reverse cardiomyopathy

Gaitani, S., Faragasso, E., Pirani, L., Fucili, A., Ceconi, C., Ferrari, R. — 2008-06-01

140 Clinical and instrumental characteristics of patients with arrhythmogenic right ventricular cardiomyopathy: 30 years of experience in a referral center

2008-06-01

141 Long term outcome of dilated cardiomyopathy: a large cohort of patients from the Heart Muscle Disease Registry of Trieste

2008-06-01

143 Cardio-vascular complications in patients with portal hypertension

Manov, E.I., Donova, T.I., Tchernev, K.G. — 2008-06-01

144 Relationship between intensive diuresis and QRS morphology change

Hoque, M.Z., Huda, N., Crudu, V., Karia, D. — 2008-06-01

145 Is the long term outcome of familial dilated cardiomyopathy different with respect to sporadic forms

2008-06-01

146 Cardiomyopathy in the course of laminopathy, emerinopathy and dystrophinopathy, genetic background and clinical presentation

2008-06-01

147 Lateral, medial or average tissue Doppler velocities for the non-invasive assessment of left ventricular filling pressures in patients with dilated cardiomiopathy?

2008-06-01

148 Nuclear changes and expression of nucleoporin p62 in ischaemic and dilated cardiomyopathy

2008-06-01

149 Perimyocarditis: clinical-echocardiographic features and medium-long-term follow-up

2008-06-01

150 Pentraxin 3: A novel biomarker for Heart failure?

Abou-Raya, S., Abou-Raya, A., Helmii, M. — 2008-06-01

151 Evaluation of the origin of exercise limitations by cardiopulmonary exercise testing in patients with suspected diastolic heart failure

2008-06-01

152 New non invasive marker of Heart Failure with pulmonary congestion: thoracic electrical bioimpedance

2008-06-01

153 Pulmonary ultrasound in diagnosis of pulmonary congestion in patients with heart failure

Tsverava, M. — 2008-06-01

154 Nocturnal pulse-oxymetry can predict poor outcomes in patients with congestive heart failure a prospective study

2008-06-01

155 Three-dimensional echocardiographic index of cardiac dyssynchrony for predicting a favorable response to cardiac resynchronization therapy

Cavallino, C., Marti, G., Sarasso, G., Occhetta, E., Marino, P.N. — 2008-06-01

156 Prediction of raised pulmonary wedge pressure in mitral valve disease by a new tissue doppler based diastolic time interval

Chaturvedi, V., Seth, S., Roy, A., Bahl, V.K. — 2008-06-01

157 Tissue Doppler Imaging: a reliable method for estimation of the left ventricular end-diastolic pressure in patients with chronic heart failure

2008-06-01

158 Doppler parameters predicting echocardiographic response and improved survival after initiation of cardiac resynchronization therapy

2008-06-01

159 Does ischemic mitral regurgitation have an impact on the right ventricular function in patients after myocardial infarction?

Oryshchyn, N.D., Ivaniv, Y.A., Pavlyk, S.S. — 2008-06-01

160 Impact of ischemic mitral regurgitation on left ventricle function in patients with ST elevation myocardial infarction treated with primary percutaneus interventions

2008-06-01

161 Assessment the reliability of classic and modern echocardiographic indices in the evaluation of left ventricular diastolic function

2008-06-01

162 Predicting subclinical heart failure in patients with mild to moderate aortic stenosis: a substudy of the ASTRONOMER study

Tarn, J., Jassal, D.S., Chan, K.L. — 2008-06-01

163 Atrial electromechanical coupling interval as a possible predictive factor for heart failure in a distant future

2008-06-01

164 Echocardiographic evaluation at rest and exercise capacity in systolic heart failure

2008-06-01

165 Tissue Doppler imaging and N-terminal protype-B natriuretic peptide aid risk stratification of patients with systolic heart failure who are stable under medical treatment

Dini, F.L., Fontanive, P., Ciuti, M., Chella, P.S., De Tommasi, S.M. — 2008-06-01

166 Relation of myocardial blush grade to diastolic myocardial function evaluated by Tissue Doppler Echocardiography after primary or rescue percutaneous coronary intervention

2008-06-01

167 Use of 2D longitudinal strain to monitor myocardial recovery during biventricular assistance in patients with fulminant myocarditis

2008-06-01

168 Left ventricular remodeling after surgical ventricular restoration in patients with end-stage ischemic cardiomyopathy

Vaskelyte, J., Raugeliene, R., Marcinkeviciene, J., Kavoliuniene, A. — 2008-06-01

169 Contrast-enhanced cardiovascular magnetic resonance predicts all cause mortality in patients with heart failure and systolic dysfunction of uncertain etiology

2008-06-01

170 Impact of high dose metoprolol on left ventricular function and volumes assessed by cardiac magnetic resonance tomography

Jensen, C., Geckeis, K., Jochims, M., Bell, M., Sabin, G.V., Bruder, O. — 2008-06-01

171 Myocardial Inflammation in Autoimmune Diseases: Evaluation using cardiovascular magnetic resonance imaging

2008-06-01

188 Protein kinase C alpha and epsilon reduce Ca-sensitivity of force development in human myocardium by phosphorylation of troponin

Van Der Velden, J., Kooij, V., Zaremba, R., Boontje, N.M., Stienen, G.J.M. — 2008-06-01

189 Cardiac function during mild hypothermia in human-sized pigs: Increased inotropy at the cost of diastolic dysfunction

2008-06-01

190 Antiviral activity of coxsackievirus B3 3C protease inhibitor

Jeon, E.-S., Yun, S.H., Kim, D.K., Cho, M.C., Choi, D.J., Kim, J.J., Ryu, K.H. — 2008-06-01

191 Myocyte function and gene defects in arrythmogenic right ventricular dysplasia: clinical pnehotypes and open problems

2008-06-01

192 Interferon beta improves endothelial damage and normalises the number of circulating endothelial progenitor cells in parvovirus B19 positive inflammatory cardiomyopathy

2008-06-01

228 Cardiac dystrophinopathies: prevalence and clinical phenotypes in a consecutive series of 408 males with idiopathic dilated cardiomyopathy

2008-06-01

229 Effects of rolofylline, a new adenosine A1 receptor antagonist, on symptoms, renal function and outcomes in patients with acute heart failure. Results of the PROTECT pilot study

2008-06-01

230 Trends in long-term mortality among men and women with ischemic and non-ischemic heart failure in Sweden

Shafazand, M., Schaufelberger, M., Swedberg, K., Rosengren, A. — 2008-06-01

231 Cost of drug therapy in outpatients in a heart failure clinics in real life. Data to plan new strategies in the optimal use of heart failure clinic resources

Bocchi, E.A., Cruz, F., Santos, V.G., Galanti, M.C., Silva, G.W.B. — 2008-06-01

232 New perspectives on the causes and consequences of heart failure in a black urban population in South Africa: The Heart of Soweto Study

2008-06-01

241 Effectiveness and feasibility of a structured group-based self-management programme among congestive heart failure patients in The Netherlands

2008-06-01

242 Long term follow-up of older patients in a heart failure disease management programme

2008-06-01

243 Multicenter randomised trial on home based telemanagement to prevent hospital readmission of patients with chronic heart failure

2008-06-01

244 How often do heart failure patients perceive adverse effects of their medication and how do they deal with them?

De Smedt, R.H.E., Jaarsma, T., Haaijer-Ruskamp, F.M. — 2008-06-01

245 Developing Group Education Sessions for Low-Risk Heart Failure Patients attending a Heart Failure Unit

Ryder, M., Murphy, N.F., McCaffrey, D., Ledwidge, M., McDonald, K. — 2008-06-01

246 Clinical implications of the QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from the EVEREST program

2008-06-01

247 A relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure

Oh, J., Kang, S.M., Lee, S.H., Park, S., Shin, M.J., Jang, Y., Chung, N. — 2008-06-01

248 The type of acute heart failure significantly affects the costs of hospitalization

2008-06-01

249 Cystatin C, inflammatory markers and prognosis in acute heart failure: insights into the cardiorenal syndrome

2008-06-01

250 Mode of death and cardiovascular re-hospitalization in patients admitted with acute heart failure - results from the EVEREST program

2008-06-01

251 Coronary angiography, subsequent use of medical therapy/revascularization, and survival in acute heart failure: a report from OPTIMIZE-HF

2008-06-01

252 Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction

2008-06-01

253 International comparison of clinical use of inotrope and vasodilator therapy for acute decompensated heart failure

2008-06-01

254 Mortality and variables associated with heart failure on admission in patients with acute myocardial infarction

2008-06-01

255 Hemodynamic support for cardiogenic shock with tandem heart device

Gupta, M., Polena, S., Coplan, N., Cohen, H. — 2008-06-01

256 Prediction of 1-year outcomes after an acute heart failure hospitalisation: importance of variables measured at the time of discharge

2008-06-01

257 Multimarker strategy to predict 6-month mortality after admission for acute heart failure

2008-06-01

258 Acute heart failure with preserved ejection fraction and long-term Readmisions

2008-06-01

259 Using Surface Thoracic Bioimpedance for monitoring patients with risk development of Acute Heart Failure. New experience

2008-06-01

260 Large QRS at hospital admission is not a negative prognostic marker in acute heart failure

2008-06-01

261 Precipitating factors for decompensation of chronic heart failure (HF): their relationship with in-hospital outcome

2008-06-01

262 AHEAD - Acute HEArt failure Database - preliminary data of the main study

2008-06-01

263 Classifying patients with acute heart failure: Presentation treatment and outcome. A ten country survey of acute heart failure management (ALARM-HF)

2008-06-01

264 Long-term prognosis in patients with acute ST-segment elevation myocardial infarction and acute heart failure: prospective randomized study

Kozhukhov, S., Parkhomenko, A. — 2008-06-01

265 Acute heart failure with preserved systolic function in acute coronary syndrome patients: clinical relevance and outcomes

2008-06-01

266 Incidence predictors at admission and impact of worsening renal function among patients hospitalized for acutely decompensated idiopathic dilated cardiomyopathy

2008-06-01

267 Effects of tolvaptan on physician-assessed signs and symptoms in patients admitted with acute heart failure - results from the EVEREST program

2008-06-01

268 Comparison of Levosimendan Effects in Chagasic versus Non Chagasic Etiology in Decompensated Systolic Heart Failure Patients

2008-06-01

269 Predictors of heart failure development after non-ST elevation myocardial infarction

2008-06-01

270 Efficiency and safety of prolonged levosimendan infusion in patients with acute heart failure

Aidonidis, G., Kanonidis, I., Neumann, T., Sakadamis, G., Erbel, R. — 2008-06-01

271 How do clinicians diagnose acute heart failure?

Murphy, J.J., Fuat, A., Hancock, H., Mason, J. — 2008-06-01

272 Left main disease and postprocedural TIMI 3, but not TIMI 2, coronary blood flow predict survival in patients with cardiogenic shock complicating acute myocardial infarction

2008-06-01

273 Role of fluid retention in patients hospitalised for acute heart failure

2008-06-01

274 Association of higher ultrafiltration rates and increased creatinine levels during ultrafiltration in decompensated heart failure

Thomas, M., Parle, N.M., Dembo, L., O'Driscoll, G. — 2008-06-01

275 The importance of the initial values of serum creatinine and glomerular filtration rate to short-term prognosis for patients with acute heart failure

Zambrzycki, J.A.N.S., Marszalek, A., Trzeszczkowski, L. — 2008-06-01

276 Risk stratification for recurrent heart failure in post-myocardial infarction patients with electrocardiographic and echocardiographic left atrial abnormality

Ariyarajah, V., Malinski, M., Zieroth, S., Harizi, R., Morris, A., Spodick, D.H. — 2008-06-01

277 Acute decompensated heart failure is associated with increased serum level of oxidative stress

2008-06-01

278 Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes

2008-06-01

279 Left ventricular diastolic dysfunction in major beta thalassemia

Ramezani, M.S., Saravi, M., Tamaddoni, A. — 2008-06-01

280 The early assessment of dyspnea in patients with acute heart failure syndromes - the Ularitide Global Evaluation in Acute Decompensated Heart Failure (URGENT) study

2008-06-01

281 Chronic obstructive pulmonary disease with pleural transudate or pulmonary oedema?

2008-06-01

282 Acute heart failure syndromes: different entities with different prognosis

2008-06-01

283 Prognostic Value of B-type natriuretic peptide (BNP) in Patients With Left Bundle-Branch Block in patients admitted for acute heart failure (AHF)

2008-06-01

284 Stratification of mortality by risk scores from the EPHESUS trial reveals significant interaction between left ventricular ejection fraction and Killip class

Pitt, B., Zannad, F., Van Veldhuisen, D.J., Sutradhar, S., Vincent, J. — 2008-06-01

285 Preliminary report on the effects of ultrafiltration in severe heart failure: the Continuous Ultrafiltration for cOngestive heaRt failurE (CUORE) trial

2008-06-01

286 De novo acute heart failure and acutely decompensated chronic heart failure: one single syndrome or two different entities?

2008-06-01

287 Relationship between peak cardiac power output and selected cardio-pulmonary variables in patients on left ventricular assist devices explanted patients and those with severe heart failure

2008-06-01

288 Interval training effects on oxygen kinetics in heart failure patients

2008-06-01

289 Can normalization for peak oxygen uptake of ventilatory response increase prognostic power of cardiopulmonary exercise test in patients with chronic heart failure?

2008-06-01

290 Attenuated heart rate recovery is a strong predictor of mortality in patients with left ventricular systolic dysfunction

Carmo, P., Ferreira, A., Aguiar, C., Feliciano, S., Mendes, M., Silva, A. — 2008-06-01

291 A cutoff point for peak VO2 with beta-blocker therapy in heart failure patients

2008-06-01

292 A study comparing validity and reliability of the incremental shuttle walk test and 6-minute walk test in chronic heart failure

Cowie, A., Thow, M., Granat, M., Mitchell, S. — 2008-06-01

293 Exercise capacity in children after surgical correction of tetralogy of Fallot

Pietrucha, B.J., Rudzinski, A. — 2008-06-01

294 The evaluation of exercise dyspnoea by Cardio-Pulmonary Exercise Test (CPET) in patients with WPW pattern in ECG

2008-06-01

295 Determinants and prognostic value of the VE/VCO2 slope in elderly patients with stable coronary artery disease

2008-06-01

296 Oxygen uptake efficiency slope (OUES) correlates with BNP in patients with heart failure

Straburzynska-Migaj, E., Gwizdala, A., Siniawski, A., Grajek, S., Ochotny, R. — 2008-06-01

297 Elevated BNP production indicates a fibrotic process in a hypertensive population

2008-06-01

298 Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure

Dini, F.L., Gabutti, A., Fontanive, P., Passino, C., Emdin, M., De Tommasi, S.M. — 2008-06-01

299 Circulating proinflammatory cytokines natriuretic peptides and the soluble Fas/Fas ligand system are related to asymptomatic LV dysfunction in breast cancer patients receiving cardiotoxic chemotherap

2008-06-01

300 Evaluation of the expression of transcripts coding for CNP and for its specific receptor NPR-B by Real Time PCR in cardiac tissue of normal and heart failure animals

Del Ry, S., Cabiati, M., Lionetti, V., Emdin, M., Recchia, F.A., Giannessi, D. — 2008-06-01

301 Role of natriuretic peptides and troponin in the evaluation of not-high-dose anthracycline-induced cardiotoxicity

2008-06-01

302 Elevated BNP is associated with exaggerated fibroproliferative responses in patients at risk of developing cardiac fibrosis and diastolic heart failure

Watson, C.J., Phelan, D., Collier, P., Ledwidge, M., McDonald, K., Baugh, J. — 2008-06-01

303 Plasma MR-proANP is a stronger predictor of heart failure readmissions after acute myocardial infarction: Comparison with NT-proBNP

2008-06-01

304 Elevated BNP at Discharge: Are Patients truly euvolaemic?

Ali, M., Arnous, S., Ledwidge, M., Murphy, M., Murphy, N., McDonald, K. — 2008-06-01

305 Urinary NT-proBNP independently predicts cardiovascular outcome in patients with chronic heart failure

2008-06-01

306 Clinical and neurohormonal correlates of Dual Energy X-Ray Absorbtiometry (DEXA) body fat indices in patients with heart failure

2008-06-01

307 IntranasalaAdministration of atrial natriutetic peptide attenuates left ventricular remodeling and dysfunction associated with acute myocardial infarction in rats

Kono, T., Soyama, A., Kitaura, Y. — 2008-06-01

308 N-terminal Pro-B-Type natiuretic peptide and the metabolic syndrome synergistically predict total and vascular mortality after coronary angiography: Prospective data from the LURIC cohort

2008-06-01

309 The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure-comparison with conventional methods of prognostication

Kubanek, M., Goode, K., Lanska, V., Clark, A.L., Cleland, J.G.F. — 2008-06-01

310 Nt-pro-BNP in heart failure patients is influenced by short-term changes in circulating insulin levels

Halbirk, M., Noerrelund, H., Rasmussen, L.M., Boetker, H.E., Wiggers, H. — 2008-06-01

311 Hyporresponsiveness to bnp in chronic advanced heart failure: fact or myth?

Lourenco, P., Araujo, J.P., Azevedo, A., Bettencourt, P. — 2008-06-01

312 The impact of n terminal pro natriuretic peptide (NT pro BNP) on number needed to screen of patients referred from the community to one stop heart failure clinics. prospective observational study

Barjas, M. A., Nair, D., Davar, J. — 2008-06-01

313 B-type natriuretic peptide (BNP) regulation and Doppler echocardiographic alterations in patients with chronic obstructive pulmonary disease acute exacerbations

Botelho, C.M.A., Pena, J.L.B., Colosimo, E.A., Moreira, M.C.V. — 2008-06-01

314 Relationship between intermittent infusion of levosimendan and reduction of plasmatic bnp levels in patients with advanced heart failure

2008-06-01

315 Brain natriuretic peptide might predict an abnormal geometry in children with chronic kidney disease

Hedvig, J., Podracka, L., Potocekova, D. — 2008-06-01

316 BNP a predictor of "ongoing morbidity burden" in stable heart failure population

Jan, A., Ledwidge, M., Murphy, N.F., McCaffrey, D., O'Loughlin, C., McDonald, K. — 2008-06-01

317 Plasma NT-proBNP of the very elderly in the general population: a prospective study

Vaes, B., De Ruijter, W., Degryse, J., Westendorp, R.G.J., Gussekloo, J. — 2008-06-01

318 NYHA Specific Activity Questionnaire score and NT-proBNP predict aerobic capacity

Athanasopoulos, L.V., Dritsas, A., Cokkinos, D.V. — 2008-06-01

319 Creation of dialysis vascular access with normal flow increases BNP levels

Malik, J., Tuka, V., Kasalova, Z., Slavikova, M. — 2008-06-01

320 Determinants of BNP (Bayer) and NT-proBNP (Roche) in patients with suspected heart failure: A comprehensive and validated analysis

Goode, K., Clark, A.L., Kilpatrick, E.S., Price, C.P., Cleland, J.G. — 2008-06-01

321 The Importance of NT-ProBNP determination at first time observation in ambulatory heart failure patients in general cardiology setting

Sargento, L., Lopes, M.G. — 2008-06-01

322 Prognostic value of BNP reduction after levosimendan administration

2008-06-01

323Changes of NT proBNP correlated with the regression of left ventricular hypertrophy in patients with aortic valve replacement

Jeon, E.-S., Park, P.W., Sung, K.I., Choi, D.J., Kim, J.J., Cho, M.C., Ryu, K.H. — 2008-06-01

324 NT-pro BNP is a better biomarker than BNP for the identification of left ventricular dysfunction in beta-thalassemia major patients

2008-06-01

325 Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - findings from the I-PRESERVE trial

2008-06-01

326 Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF-PEF). Findings from the I-PRESERVE trial

2008-06-01

327 Loss of weight and mortality in heart failure

2008-06-01

328 Prevalence and prognostic significance of gamma-glutamyltransferase (GGT) in chronic heart failure

2008-06-01

329 Predictors of outcome in heart failure with preserved ejection fraction: one year findings rom the Irbesartan in Heart Failure With Preserved Systolic Function Trial (I-PRESERVE)

2008-06-01

330 Beta-adrenoceptor polymorphisms in heart failure: Does altered receptor function modify long-term survival in advanced heart failure?

2008-06-01

331 Prevalence and prognostic impact of right ventricular dilation in patients with moderate chronic heart failure. A cardiac-MRI study

2008-06-01

332 Nocturnal periodic breathing oxygen desaturations and mortality in heart failure patients

2008-06-01

333 Prognostic value of right ventricular dysfunction and pulmonary artery hypertension parameters for risk stratification of patients with heart failure

2008-06-01

334 The prognostic value of individual NTproBNP values in chronic heart failure does not change with advancing age; a hint to biological ageing

2008-06-01

335 Do Angiotensin-converting enzyme (types 1 and 2) gene polymorphisms modify long-term survival in advanced heart failure?

2008-06-01

336 Prognostic role of subclinical hypotyroidism in a group of outpatients with chronic heart failure

2008-06-01

337 Acute heart failure as de novo vs. chronic heart failure: differences in clinical syndrome and long-term prognosis

2008-06-01

338 Beta-1 adrenoceptor gene polimorphism in heart failure: clinical and prognostic significance in female patients

2008-06-01

339 Functional non ischemic mitral regurgitation predicts death or heart transplant among patients with systolic heart failure followed at a dedicated heart failure outpatient clinic

2008-06-01

340 Incremental value of NT-proBNP and E/E' ratio in predicting heart failure progression

2008-06-01

341 Trends in hospitalization due to Congestive feart failure in Austria, 1990-2004

Kozanli, I., Cilesiz, D., Jarai, R., Jakl, G., Huber, K. — 2008-06-01

342 Chronic obstructive pulmonary disease in patients with chronic heart failure-important factor affecting long term follow-up

Roik, M., Starczewska, M.H., Kochanowski, J., Huczek, Z., Opolski, G. — 2008-06-01

343 Does the prognostic impact of renal dysfunction in heart failure depend on the formula used to estimate glomerular filtration rate?

Coceani, M., Carpeggiani, C., Ripoli, A., L'abbate, A. — 2008-06-01

344 Prevalence and prognostic significance of intraventricular dyssynchrony in patients with heart failure narrow QRS and preserved ejection fraction

De Sutter, J.H.A.J., Van De Veire, N.R., De Buyzere, M. — 2008-06-01

345 The Cardiovascular Medicine-HF index is useful in estimating the use of resources in heart failure elderly patients

Pulignano, G., Del Sindaco, D., Senni, M., Gavazzi, A. — 2008-06-01

346 Clinical correlates and prognostic value of Duke's Activity Status Index in chronic heart failure

2008-06-01

347 The inverse correlation between body mass index and 5-year mortality after invasively treated ST-elevation myocardial infarction

2008-06-01

348 Influence of hospital admission area on the prognosis of heart failure patients

2008-06-01

349 Self-rated health in patients with chronic heart failure: distribution and association with mortality

Farkas, J., Nabb, S.L., Zaletel-Kragelj, L., Cleland, J.G.F., Lainscak, M. — 2008-06-01

350 Cardiorenal syndrome: a silent but deadly complication in acute coronary syndrome patients

2008-06-01

351 Incidence and significance of atrial fibrillation in octogenarian patients with acute myocardial infarction

2008-06-01

352 Kansas City Cardiomyopathy Questionnaire is associated with immune and neurohormonal activation and predicts long-term outcome in outpatients with chronic heart failure

2008-06-01

353 Gender differences in patients admitted with advanced decompensated heart failure

2008-06-01

354 The impact of mild and moderate anemia on 31-day mortality in patients with acutely decompensated low output chronic heart failure

2008-06-01

355 Short-term prognosis markers in patients admitted for worsening heart failure

2008-06-01

356 Triiodothyronine has similar value with brain natriuretic peptide for predicting survival in patients with chronic heart failure

2008-06-01

357 prognostic evaluation of elderly patients with chronic heart failure and depressed or preserved left ventricular function:role of multiparametric stratification

2008-06-01

358 Progressive heart failure in patients with endocarditis: short and long term prognosis

Abramczuk, E., Hryniewiecki, T.T., Stepinska, J. — 2008-06-01

359 Myostatin serum levels in heart failure

2008-06-01

360 Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure

2008-06-01

361 Prognostic value of HSCRP in recently decompensated HF patients

2008-06-01

362 The evolution of anaemia over time in a stable community heart failure population

2008-06-01

363 Prognostic significance of atrial fibrillation in elderly patients with heart failure

2008-06-01

364 Risk stratification of patients with chronic heart failure based on metabolic functional and haemodynamic parameters

Herrmann, R., Sandek, A., Doehner, W., Dietz, R., Anker, S.D., Rauchhaus, M. — 2008-06-01

365 Significance of atrial fibrillation in octogenarian patients with acute myocardial infarction

2008-06-01

366 Antecedent of heart failure is not independently associated with 31-day mortality in octogenarian patients with acute myocardial infarction

2008-06-01

367 Why chagasic patients have acute worse prognostic than other etiologies?

2008-06-01

368 Dismal prognosis of patients with post-acute coronary syndrome severe left ventricular dysfunction: how to predict it?

2008-06-01

369 Independent role of resting heart rate at discharge as a predictor of mortality after a hospitalisation for acute heart failure

2008-06-01

370 Influence of heart failure on prognosis of patients with acute myocardial infarction

2008-06-01

371 Short-term day-time periodic breathing is not a risk factor for life-threatening arrhythmias in patients with heart failure

La Rovere, M.T., Pinna, G.D., Maestri, R., Olmetti, F., Robbi, E., Febo, O. — 2008-06-01

372 The Seattle Heart Failure Model and BNP in prediction of mortality in patients with severe heart failure

Lesny, P., Luknar, M., Goncalves, E. — 2008-06-01

373 Different prognostic value of E/E' ratio evaluated at the level of septal and lateral mitral anulus in predicting short-term risk of heart failure progression

2008-06-01

374 Proteolysis peculiarities in Q-wave myocardial infarction with dilatation postinfarction remodeling

Koval, O., Ivanov, A., Mararenko, O., Dzyak, G. — 2008-06-01

375 Does blood urea concentration predict early mortality in patients hospitalised with decompensated Heart Failure (HF) better than estimated glomerular filtration rate (eGFR)?

2008-06-01

433 Regression analysis of mortality data from the EPHESUS trial reveals significantly higher risk of death for patients with non-ST segment elevation myocardial infarction

Zannad, F., Pitt, B., Filippatos, G., Sutradhar, S., Vincent, J., Bauersachs, J. — 2008-06-01

434 Intra-thoracic impedance fluid index alerts are associated with increased risk for heart failure hospitalization

2008-06-01

435 Diuretic use in patients with systolic chronic heart failure: a German competence network heart failure experience

Rauchhaus, M. — 2008-06-01

436 Prospective comparative study on improvement of HRQoL n Heart transplant recipients and outpatients after implantation of a Left Ventricular Assist Device (HeartMate II)

2008-06-01

437 Tubular damage is prevalent in chronic heart failure and associated with renal dysfunction and prognosis

2008-06-01

438 Usefulness of cardiac magnetic resonance in assessing reverse right ventricular remodeling in patients with chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy

2008-06-01

439 Value of strain and strain rate imaging in predicting adverse outcomes in patients with chronic pulmonary arterial hypertension

2008-06-01

440 Effect of Nebivolol and Carvedilol on insulin resistance in Chronic Heart Failure patients

2008-06-01

441 Correction of myofilament function by beta-blocker therapy in post-infarct remodeled myocardium

2008-06-01

442 Effect of sinus rhythm restoration in patients with atrial fibrillation on platelets function

2008-06-01

443 Direct evidence for activation of the neuregulin-1/ErbB system in myocardium of dogs with pacing-induced heart failure

Doggen, K., Ray, L., Mathieu, M., McEntee, K., Lemmens, K., De Keulenaer, G.W. — 2008-06-01

444 Regional myocardial hybernation detected by low-dose dobutamine stress MRI in minipigs with prolonged left ventricular dyssynchronous contraction

2008-06-01

445 A novel alternative spliced variant of the brain natriuretic peptide gene is superior to BNP as a molecular marker of ventricular dysfunction

Torrado, M., Iglesias, R., Centeno, A., Mikhailov, A.T. — 2008-06-01

446 Overexpression of the transcription factor Hand1 causes sudden cardiac death in mice

2008-06-01

447 Chronic adenosine receptor blockade with BG9928 attenuates cardiac and renal histopathology and improves diabetes in animals with the metabolic syndrome

Tofovic, S., Salah, E.M., Smits, G., Whalley, E.T., Ticho, B., Jackson, E.K. — 2008-06-01

448 Controlled reperfusion with adiponectin in porcine myocardial infarction model

2008-06-01

449 effect of pravastatin on left ventricular remodeling and endothelin-1 in pacing-induced canine of heart failure

Zhao, D.R., Zhao, M., Jia, S.Q. — 2008-06-01

450 Effects of in vivo neuregulin-1/ErbB activation on diabetes-induced myocardial dysfunction in the rat

Doggen, K., Lemmens, K., De Keulenaer, G.W. — 2008-06-01

451 Bisoprolol in experimental cancer cachexia

2008-06-01

452 Isolation and characterization of pluripotent cells from the subendocardial layer of human hearts from chronic heart failure patients

2008-06-01

453 Allopurinol increases endothelial progenitor cell number in patients with heart failure

2008-06-01

454 Activation of the adenosine-A3 receptor facilitates monocytes/macrophages migration through enhanced Matrix Metalloproteinase-9 Secretion

Velot, E., Haas, B., Ernens, I., Longrois, D., Devaux, Y., Wagner, D.R. — 2008-06-01

455 Neuregulin 1beta modulates cell-matrix interaction in myocytes via Src/Fak

Pentassuglia, L., Kuramochi, Y., Lim, C.C., Arteaga, C., Sawyer, D.B. — 2008-06-01

456 Marked decrease in myocardial capillary density of patients with congestive heart failure due to idiopathic dilated cardiomyopathy and depressed coronary flow reserve

2008-06-01

457 Clinical presentation of in-stent restenosis - experience from Western Sweden

Omerovic, E., Ramunddal, T., Matejka, G., Albertsson, P. — 2008-06-01

458 Electrophysiological effects after intramyocardial injection of mesenchymal vs. mononuclear bone marrow derived stem cells in the chronic ischaemic myocardium

Krause, K., Jaquet, K., Lange, C., Schneider, C., Koektuerk, B., Kuck, K.-H. — 2008-06-01

459 Cardiac study. effect of autologous intracoronary mononuclear bone marrow cell transplantation in humans in patients after acute anterior myocardial infarction with left ventricular dysfunction

2008-06-01

460 Autologous and allogenic stem cell technologies in the treatment of patients with congestive heart failure: clinical experience

2008-06-01

461 Effects of intravenous injections of hypoxia-conditioned bone marrow-derived stem cell medium in dogs with heart failure

Rastogi, S., Sharov, V.G., Sabbah, H.N. — 2008-06-01

462 Autologous 5-azacytidine-cultured bone-marrow stem cells in surgical treatment of heart failure

2008-06-01

463 Intramyocardial injections of naked plasmid encoding hepatocyte growth factor normalize matrix metalloproteinases in dogs with heart failure

Rastogi, S., Sharov, V.G., Sabbah, H.N. — 2008-06-01

464 Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-Type natriuretic peptide in patients with Chronic Heart Failure: Prediction of death at different stages of the disease

2008-06-01

465 Effects of six months testosterone supplementation in elderly female patients with chronic heart failure

2008-06-01

466 Influence of matrix and hormonal stimuli on human cardiac fibroblast activity

Phelan, D., Watson, C.J., Collier, P., Ledwidge, M., Baugh, J., McDonald, K. — 2008-06-01

467 Association between cardiotrophin-1 overexpression and myocardial remodelling in experimental hyperaldosteronism

2008-06-01

468 Physical training lowers circulating adiponectin levels in patients with chronic heart failure

2008-06-01

469 Urotensin II and Urocortin promote adult rat cardiomyocytes hypertrophy together with phosphorylation of the Protein Kinase B- Glycogen Synthase Kinase 3b pathway and stabilization of b-catenin

2008-06-01

470 Coronary microvascular impairment is related to increased plasma levels of osteopontin in patients with idiopathic left ventricular dysfunction

2008-06-01

471 Consequences of aldosterone administration on cardiac ion currents in rats

2008-06-01

472 EAdministration of Apelin modulates myocardial expression of Apelin-APJ and improves right ventricular performance in MCT-induced pulmonary hypertension

2008-06-01

473 Sexual complaints in men with chronic heart failure: prevalence and hormone determinants

2008-06-01

474 Urotensin II-induced increase in myocardial distensibility is modulated by angiotensin and endothelin systems

Fontes-Sousa, A.P., Pires, A.L., Leite-Moreira, A.F. — 2008-06-01

475 TThe acute decrease of myocardial stiffness induced by adrenomedullin is dependent of the endocardial endothelium and nitric oxide release

2008-06-01

476 Alpha-adrenergic system as a novel regulatory system of myocardial stiffness in health and disease

2008-06-01

477 Type B natriuretic peptyde concentration and cardiopulmonary exercise testing in adult patients with right ventricle anomaly

2008-06-01

478 The urocortin 2-induced decrease in myocardial stiffness is compromised in heart failure

Bras-Silva, C., Fontes-Sousa, A.P., Mendes, S., Almeida, M., Leite-Moreira, A.F. — 2008-06-01

479 Increased inotropic and lusitropic responses to urocortin 2 in the presence of endocardial endothelial dysfunction

Bras-Silva, C., Fontes-Sousa, A.P., Almeida, M., Mendes, S., Leite-Moreira, A.F. — 2008-06-01

480 Differences in the myocardial hypertrophic response in two types of pressure overload

2008-06-01

482 Correlation between development of target organs damage and chronic heart failure in patients with uncomplicated arterial hypertension

Shatunova, I., Lazarev, I., Koziolova, N. — 2008-06-01

483 The Acute increase of Myocardial Distensibility induced by Beta-adrenergic Stimulation is blunted in Hypertensive Diabetic Rats

Falcao-Pires, I., Goncalves, N., Leite-Moreira, A.F. — 2008-06-01

484 Tissue inhibitor of matrix metalloproteinase-1 and left ventricle performance in patients with aortic stenosis

Goncharova, N.S., Moiseeva, O.M., Aleshina, G.A., Shlykhto, E.V. — 2008-06-01

485 Left ventricular mass regression after aortic valve replacement in patients with isolated aortic stenosis

2008-06-01

486 Atrial Fibrillation in hypertensive left ventricular hypertrophy: Serum concentrations of soluble Fas and soluble Fas ligand

2008-06-01

487 Changes of LV remodeling and diastolic function in patients with arterial hypertension during two years follow up

Stevanovic, A., Dekleva, M., Sevic, L.J. — 2008-06-01

488 Non invasive assessment of coronary flow in patients with hypertrophic cardiomyopathy: a case control study

2008-06-01

489 Gender aspects on systolic heart failure in the elderly: the prognostic importance of left ventricular mass in women

Mejhert, M., Kahan, T., Edner, M., Persson, H. — 2008-06-01

490 Changing mortality in dilated cardiomyopathy in the last 30 years: the experience oh the heart muscle disease registry of trieste

2008-06-01

491 Pentraxin 3: A new biomarker for the diagnosis of both symptomatic and asymptomatic left ventricular systolic dysfunction in the elderly?

Abou-Raya, S., Abou-Raya, A., Helmii, M. — 2008-06-01

492 Assessment of swine left ventricular torsion after left coronary artery occlusion using 2-D speckle tracking imaging

Ruan, W., Sun, Y.G., Cao, M., Zhang, Q., Lu, L., Shen, W.F. — 2008-06-01

493 Diastolic heart failure in patients with isolated aortic stenosis

2008-06-01

494 Low hematocrite seems to correlate with impaired left ventricular relaxation, estimated by color M-mode flow propagation, in patients with heart failure

2008-06-01

495 Congestive heart failure with preserved systolic function in elderly patients: influence of the treatment with ACE inhibitor and beta-blocker on erythrocyte membrane proteins

Soya, O.V., Kuryata, O.V., Nedzvedskiy, V.S. — 2008-06-01

496 Inflammation exerts influence on myocardial structure and function in absence of concomitant cardiovascular diseases in patients with rheumatoid arthritis

Myasoedova, E., Myasoedova, S., Shostak, N., Obzherina, S., Svyatova, N. — 2008-06-01

497 Relation between left ventricular systolic function assessed at rest and peak stress and basic spiroergometric parameters

2008-06-01

498 Influence of platelet function on long-term LV performance in myocardial infarction treated with primary angioplasty

Huczek, Z., Filipiak, K.J., Kochman, J., Piatkowski, R., Roik, M., Opolski, G. — 2008-06-01

499 Rate and reasons of statins prescription in patients with congestive heart failure

2008-06-01

500 The relation between brain natriuretic peptide (BNP) serum level, echocardiographic Tei index and the degree of a diastolic function in patients with diastolic heart failure

Karasek, D., Sinkiewicz, W., Blazejewski, J., Bujak, R. — 2008-06-01

501 NYHA class II subgrouping: correlation with left ventricular dysfunction questionnaire (LVD-36) and ejection fraction

2008-06-01

502 A novel index combining diastolic and systolic tissue Doppler parameters: correlation with NTproBNP levels in patients with left ventricular dysfunction

2008-06-01

503 LV performance and exercise capacity in patients aged 65 years and older treated by early coronary angioplasty or conservatively for acute myocardial infarction: a one year follow-up

Pawlowska-Jenerowicz, W., Drewniak, W., Dabrowski, M. — 2008-06-01

504 Elevated homocysteine level, risk factor for left ventricular dysfunction in prior myocardial infarction patients

2008-06-01

505 Sleep apnea in heart failure in heart failure. Effects of continuous positive airway pressure on cardiovascular outcomes

2008-06-01

506 Evidence of bisoprolol-induced left ventricular function improvement, by the Tei index analysis, in patients with systolic heart failure

2008-06-01

507 Ongoing improvement in mitral regurgitation in optimally treated chronic heart failure patients

2008-06-01

508 Time course changes in diastolic function induced by surgical ventricular restoration

Di Donato, M., Castelvecchio, S., Frigiola, A., Menicanti, L. — 2008-06-01

509 Systolic function reserve in assessment of treatment efficient 12 months after coronary artery surgery and drug therapy in patients with coronary heart disease

Hyshova, N., Bobrov, A., Karpenko, M. — 2008-06-01

510 Association of right ventricular dysfuction and left ventricle dilatation in heart failure patients

2008-06-01

511 Left atrial size in diabetic and non-diabetic subjects

Karmakar, P. — 2008-06-01

512 Relation of Left bundle branch block in type II diabetes mellitus with left ventricular systolic function and hemoglobin A1C

Saravi, M. — 2008-06-01

513 Severity of LV diastolic dysfunction in patients with atrial fibrillation, chronic heart failure and normal LV ejection fraction

Ovchinnikov, A., Svirida, O., Ageev, F. — 2008-06-01

514 Structural and functional remodelling of the left ventricle in patients with heart failure of ischemic origin

2008-06-01

515 Patients with peoperatively depressed left ventricular systolic function due to degenerative mitral regurgitation should be treated by mitral valve repair rather than mitral valve replacement

2008-06-01

516 NCAM (CD56) and CD31 in elderly patients with hypertension and heart failure with low ejection fraction

Soya, O.V., Kuryata, O.V., Nedzvedskiy, V.S. — 2008-06-01

517 Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to Diastolic Function in Dialysis Patients

2008-06-01

518 Diastolic function in patients with Q-wave myocardial infarction with preserved ejection fraction

Vinogradova, N., Polonetsky, L., Sevruc, T., Ustinova, I. — 2008-06-01

519 Nocturnal oxyhaemoglobin desaturation and plasminogen activator inhibitor type-1 in patients with diastolic dysfunction

2008-06-01

520 Development of left ventricular systolic function of premature infant. By use of new echocardiographic tissue doppler imaging of strain and strain rate

Kikuchi, Y. — 2008-06-01

521 Left ventricular systolic dysfunction after acute coronary syndromes: incidence; prognosis and risk predictors

2008-06-01

522 Patients with metabolic syndrome are likely to have aggressive coronary disease and worse left ventricular function after non ST elevation myocardial infarction

Rao, G.K., Innasimuthu, A.L., Noronha, B., Davis, G.K. — 2008-06-01